|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2600 EUR | -0.19% |
|
0.00% | -22.85% |
| Market Cap | 13Cr 15Cr 12Cr 11Cr 22Cr 1.47TCr 22Cr 148.13Cr 58Cr 720.51Cr 57Cr 56Cr 2.49TCr | P/E 2026 * |
-17.3x | P/E 2027 * | -4x |
|---|---|---|---|---|---|
| Enterprise Value | 18.27L 20.84L 16.98L 15.59L 29.36L 20Cr 29.82L 2.02Cr 79.02L 9.84Cr 78.24L 76.55L 34Cr | EV / Sales 2026 * |
0.08x | EV / Sales 2027 * | 20.9x |
| Free-Float |
70.51% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.19% | ||
| Current month | +9.94% | ||
| 1 month | +0.97% | ||
| 3 months | -30.48% | ||
| 6 months | -10.34% | ||
| Current year | -22.85% |
| 1 week | 0.25 |  | 0.28 |
| 1 month | 0.22 | | 0.28 |
| Current year | 0.22 | | 0.81 |
| 1 year | 0.22 | | 0.81 |
| 3 years | 0.15 | | 1.04 |
| 5 years | 0.15 | | 2.29 |
| 10 years | 0.15 | | 7.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frédéric Chéreau
CEO | Chief Executive Officer | 59 | 01/06/2026 |
Laurene Danon
DFI | Director of Finance/CFO | - | 26/06/2024 |
Bernd Schmidt
CTO | Chief Tech/Sci/R&D Officer | - | 11/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 09/03/2015 | |
Julien Miara
BRD | Director/Board Member | 43 | - |
Khalil Barrage
CHM | Chairman | 61 | 30/03/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/02/26 | Redmile Biopharma Investments III LP
| Buy | Company | 1,89,28,571 | 6.2956% | |
| 31/01/26 | Sofinnova Partners SAS
| Buy | Company | 1,07,14,285 | 3.5636% | |
| 18/04/24 | Redmile Biopharma Investments III LP
| Buy | Company | 27,81,914 | 1.0091% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.19% | 0.00% | -16.67% | -20.85% | 15Cr | |
| -4.89% | -7.90% | -4.49% | +9.27% | 4.85TCr | |
| -0.14% | -1.05% | +376.39% | +583.71% | 3.9TCr | |
| +0.39% | +4.36% | +9.59% | +61.99% | 3.54TCr | |
| -1.54% | -4.48% | +24.89% | -13.03% | 3.37TCr | |
| -0.87% | -1.56% | -1.43% | +29.16% | 2.66TCr | |
| -1.28% | -5.14% | - | - | 1.68TCr | |
| -0.67% | -1.50% | +70.98% | +115.31% | 1.52TCr | |
| +1.32% | +2.29% | +14.62% | +15.52% | 1.39TCr | |
| +0.40% | -0.41% | +19.80% | -31.98% | 1.28TCr | |
| Average | -0.75% | -1.07% | +54.85% | +83.23% | 2.42TCr | |
| Weighted average by Cap. | -1.29% | -1.28% | +76.05% | +121.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.19Cr 2.49Cr 2.03Cr 1.86Cr 3.51Cr 240.86Cr 3.57Cr 24Cr 9.45Cr 117.68Cr 9.36Cr 9.16Cr 406.7Cr | 63.95L 72.95L 59.42L 54.56L 1.03Cr 70Cr 1.04Cr 7.08Cr 2.77Cr 34Cr 2.74Cr 2.68Cr 118.99Cr |
| Net income | -43.4L -49.51L -40.33L -37.03L -69.73L -48Cr -70.84L -4.8Cr -1.88Cr -23Cr -1.86Cr -1.82Cr -81Cr | -5.06Cr -5.78Cr -4.71Cr -4.32Cr -8.14Cr -558.01Cr -8.27Cr -56Cr -22Cr -272.64Cr -22Cr -21Cr -942.24Cr |
| Net Debt | -13Cr -15Cr -12Cr -11Cr -21Cr -1.45TCr -22Cr -146.1Cr -57Cr -710.67Cr -57Cr -55Cr -2.46TCr | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/26/22 | €0.2600 | -0.19% | 4,94,468 |
| 21/26/21 | €0.2605 | +5.25% | 5,72,499 |
| 20/26/20 | €0.2475 | -4.81% | 4,83,614 |
| 17/26/17 | €0.2600 | -3.35% | 6,56,834 |
| 16/26/16 | €0.2690 | -0.37% | 11,12,350 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALSEN Stock
Select your edition
All financial news and data tailored to specific country editions
